Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,237 | 4,526 | 7,813 | -274 | 1,123 |
| Depreciation Amortization | 8,063 | 5,610 | 3,766 | 1,860 | 7,263 |
| Income taxes - deferred | 1,651 | 947 | 808 | 310 | -1,139 |
| Accounts receivable | -2,480 | -1,809 | -1,908 | -830 | 3,461 |
| Accounts payable and accrued liabilities | 264 | -27 | -303 | -485 | -483 |
| Other Working Capital | -4,857 | -1,150 | -3,662 | -7,679 | 1,120 |
| Other Operating Activity | 8,511 | 6,403 | 5,231 | 2,828 | 2,665 |
| Operating Cash Flow | $15,389 | $14,500 | $11,745 | $-4,270 | $14,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,279 | -2,874 | -1,973 | -1,319 | -3,671 |
| Net Acquisitions | -40,553 | N/A | -1,000 | -1,000 | N/A |
| Purchase Of Investment | -22,723 | -22,799 | -22,875 | -5,820 | -59,917 |
| Sale Of Investment | 43,317 | 43,317 | 31,318 | 18,013 | 54,522 |
| Purchase Sale Intangibles | N/A | -1,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-25,238 | $16,644 | $5,470 | $9,874 | $-9,066 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,128 | 2,627 | 2,536 | 6 | 1,615 |
| Other Financing Activity | -2,901 | -2,429 | -2,393 | -796 | -6,263 |
| Financing Cash Flow | $10,227 | $198 | $143 | $-790 | $-4,648 |
| Exchange Rate Effect | -10 | 50 | 16 | 155 | 128 |
| Beginning Cash Position | 30,785 | 30,785 | 30,785 | 30,785 | 30,361 |
| End Cash Position | 31,153 | 62,177 | 48,159 | 35,754 | 30,785 |
| Net Cash Flow | $368 | $31,392 | $17,374 | $4,969 | $424 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,389 | 14,500 | 11,745 | -4,270 | 14,010 |
| Capital Expenditure | -5,279 | -2,874 | -1,973 | -1,319 | -3,671 |
| Free Cash Flow | 10,110 | 11,626 | 9,772 | -5,589 | 10,339 |